AUTHOR=Haidar Mansour , Timmerman Vincent 

TITLE=Autophagy as an Emerging Common Pathomechanism in Inherited Peripheral Neuropathies

JOURNAL=Frontiers in Molecular Neuroscience

VOLUME=Volume 10 - 2017

YEAR=2017

URL=https://www.frontiersin.org/journals/molecular-neuroscience/articles/10.3389/fnmol.2017.00143

DOI=10.3389/fnmol.2017.00143

ISSN=1662-5099

ABSTRACT=The inherited peripheral neuropathies comprise a growing list of genetically heterogeneous diseases. With mutations in more than 80 genes being reported to cause inherited peripheral neuropathies, a wide spectrum of functional consequences is expected to follow this genotypic diversity. Hence the search for a common pathomechanism among the different phenotypes has become the holy grail of functional research into inherited peripheral neuropathies. During the last decade, studies on several affected genes have shown a direct and/or indirect correlation with autophagy. Autophagy, a cellular homeostatic process, is required for the removal of cell aggregates, long-lived proteins and dead organelles from the cell in double-membraned vesicles destined for the lysosomes. As an evolutionarily highly conserved process, autophagy is essential for the survival and proper functioning of the cell. Recently, neuronal cells have been shown to be particularly vulnerable for disruption of the autophagic pathway. Furthermore, autophagy has been shown to be affected in various common neurodegenerative diseases of both the central and the peripheral nervous system including Alzheimer’s, Parkinson’s, and Huntington’s diseases. In this review we provide an overview of the genes involved in hereditary neuropathies which are linked to autophagy and we propose the disruption of the autophagic flux as an emerging common pathomechanism. We also shed the light on the different steps of the autophagy pathway linked to these genes. Finally, we review the concept of autophagy being a therapeutic target in inherited peripheral neuropathies, and the possibilities and challenges of this pathway-specific targeting.